Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians (Version 1: Update Alert 2)
- 1 November 2026
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (11)
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Correction: Time-dependent improvement of quality of life with teriparatide or alendronate therapy: a JOINT-05 sub-analysisJournal of Bone and Mineral Metabolism, 2026
- Therapeutic Strategies of Denosumab Sequential Therapy: A Four‐Armed Randomized Controlled TrialClinical Pharmacology & Therapeutics, 2025
- Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05Journal of Bone and Mineral Metabolism, 2025
- Therapeutic efficacy of zoledronic acid combined with calcium and calcitriol in the treatment of senile osteoporosis in elderly patientsInflammopharmacology, 2025
- Risk Factors Influencing Medication‐Related Osteonecrosis of the Jaws (MRONJ) Following Dental Extraction Among Osteoporotic Patients in TaiwanHead & Neck, 2024
- Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical TrialACR Open Rheumatology, 2023
- Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture RiskEndocrine Practice, 2023
- Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in TaiwanOsteoporosis International, 2023
- Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05Osteoporosis International, 2022
- Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With OsteoporosisJournal of Bone and Mineral Research, 2020